Patent · US Active

Newly identified peptides for use in the induction of oral tolerance in young mammals

US10092633B2 · kind B2 · utility

1Cited by

0References

18Claims

0Family size

Assignee

NESTEC S.A. · CH

Inventors

Carine Blanchard · Le Mont-sur-Lausanne, CH
Sophie Nutten · La Chaux-de-Fonds, CH
Alexandre Panchaud · Lausanne, CH

Key dates

Filing date	Dec 16, 2013
Grant date	Oct 9, 2018
Priority date	—
Expiry date	Dec 16, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/577
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to newly identified peptides of that are capable of inducing tolerance to cow's milk, especially to β-lactoglobulin. The peptides may be administered to mammals, especially to young infants who are at risk of allergy to cow's milk proteins, to induce oral tolerance to cow's milk; they may also be administered to children or adults who are allergic to cow's milk to allow “desensitization” towards the allergenic milk proteins, especially β-lactoglobulin, to occur. The peptides may also be used to induce tolerance to goat's and buffalo's milk proteins, especially β-lactoglobulin. The peptides are capable of modulating the mammalian immune response to allergens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.